F. H. Gross

• Antihypertensive agents
• Arterial hypertension
• Decision making in drug research
• Drug monitoring
• International experience with nadolol
• Iron metabolism
• Mild hypertension
• The Cardioprotective action of beta-blockers
• Antihypertensive therapy principles and practice
• Arterial hypertension
• Directions and implications of drug legislation and regulation in Europe ; and, Constraints on progress in drug development
• Enzymatic release of vasoactive peptides